Assay development and screening at SLAS2027
Jan 30 – Feb 3, 2027 San Diego, CA ~7.6k attendees Website
139 organizations at SLAS2027 present work in assay development and screening: 59 instrument, consumable and component makers, 36 academic, nonprofit and media organizations, 27 software and service companies and 17 drug developers. Between them they bring 205 presentations to the program. Most represented: AstraZeneca, GSK and Carnegie Mellon University. As of Nov 2, 2026.
| Organization | SLAS2027 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Biopharmaceutical company developing medicines in oncology, rare disease, cardiovascular, renal, metabolic and respiratory disease. | Workshop Sat Jan 30 8:30am–4:30pm Genome Editing and AI-Driven Approaches in Drug Discovery and Target Validation Workshop Sun Jan 31 8:30am–12pm Operationalizing DMTA: From Implementation to Continuous Optimization Workshop Sun Jan 31 8:30am–4:30pm An Introduction to Mass Spectrometry and its Applications within Drug Discovery Session Mon Feb 1 10am–12pm Advanced Imaging & Phenotypic Screening
Talk Mon Feb 1 10:30–10:55am Phenotypic profiling reveals targets impacting mitochondrial dysfunction in COPD Talk Mon Feb 1 11–11:25am Bioscience Technology expands capabilities and increases capacity in preclinical research. Poster Mon Feb 1 1–2pm Automation in Analytical – Is it possible? Session Mon Feb 1 2–2:45pm Encoded Libraries and Biophyscial Lead Discovery Talk Tue Feb 2 10–10:25am Advancing Autonomous Mobile Robot: Enabled Off-Hour Operations in AstraZentca Compound Management Group Poster Tue Feb 2 1–2pm Ultra-Miniaturized Optically Barcoded Micro-Chips for Faster, Disease-Relevant Multiplexed Screening Poster Tue Feb 2 2–3pm Improving Image Acquisition Efficiency Through Autonomous Robotic Integration Talk Tue Feb 2 3–3:25pm BRETSA to accelerate early small molecule discovery against challenging targets Session Tue Feb 2 3–5pm Emerging Assays and Screening Technology
Talk Tue Feb 2 4–4:25pm Building Automated Discovery Platforms for Next-Generation Drug Modalities Talk Tue Feb 2 4–4:25pm Integrating High-Content Imaging and Machine Learning for Phenotypic Drug Discovery Poster Wed Feb 3 2:30–3:30pm A Single-Liquid-Handler Workflow for Automated High-Throughput Flow Cytometry Staining Also |
GSK London, UK | |
Biopharmaceutical company developing vaccines and medicines in infectious disease, HIV, respiratory, immunology and oncology. | Talk Mon Feb 1 10–10:25am Automating DMTA to Accelerate Large Molecule Drug Discovery: The Critical Role of People in Automation Success Session Mon Feb 1 10am–12pm People at the Heart of Lab Automation: Building Skills, Careers, and Adoption
Talk Mon Feb 1 11–11:25am Validation of a scalable human liver model to enable mechanistic screening in MASLD Poster Mon Feb 1 1–2pm Chemistry First. Code Last. One Agent, Any Robot: Autonomous Synthesis Driven by Chemical Reasoning Talk Mon Feb 1 3–3:25pm Building an Automated Workcell for Autonomous, Around-the-Clock In Vitro ADME Assays and their Bioanalysis Session Mon Feb 1 3–5pm ADMET Automation Success and Innovation
Session Tue Feb 2 10am–12pm Sample Management
Session Tue Feb 2 1–1:45pm Proximity Assays Talk Tue Feb 2 3–3:25pm From Operators to Directors: Building Agentic DMTA and the Workforce to Run It Session Tue Feb 2 3–5pm Automation Technology to Maximize Lead Optimization of Antibodies, Biologics and Synthetic Peptides
Talk Wed Feb 3 11–11:25am Mitigating Challenges to Build a Translationally Relevant Human Plasmacytoid Dendritic Cell Platform for Profiling Type I Interferon Inhibitors Talk Wed Feb 3 2:30–2:55pm STELLA: Driving Reproducibility and Efficiency through the Automated Flow Cytometry Workcell |
Carnegie Mellon University Pittsburgh, PA | |
Private research university known for computer science, robotics and engineering, with a degree program in automated science. | Talk Mon Feb 1 10:30–10:55am Global Automated Science Education Guidelines Poster Mon Feb 1 1–2pm Automating Apical-Out Airway Organoid Culture Maintenance Using Robotic Liquid Handling at the CMU Cloud Lab Poster Mon Feb 1 1–2pm Closing the Loop on Open-Loop Liquid Handlers: Protocol-Aware Vision for Runtime Assurance and Recovery Poster Mon Feb 1 1–2pm simPCL: An Open-Framework Simulator and Benchmark Generator for Programmable Cloud Laboratories Poster Mon Feb 1 1–2pm Automated screen to identify BTEX degrading bacteria for brownfield bioremediation Talk Tue Feb 2 11:30–11:55am Disturbance-Aware Rescheduling, Backtracking, and Cost-Aware Planning for Time-Constrained Laboratory Automation Scheduling Session Tue Feb 2 2–2:45pm Automated Science Education Talk Wed Feb 3 11:30–11:55am Closing the Loop on Antibiotic Discovery: ML-Guided Automated Screening of the Bacterial Mur Pathway |
NIH center that develops technologies, assays and screening resources to speed research into treatments. | Booth Exhibiting at Booth 1461 Mon, Feb 19:30am–6:00pmTue, Feb 29:00am–5:00pmWed, Feb 39:00am–1:00pm Workshop Sat Jan 30 8:15am–5pm Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Talk Mon Feb 1 11:30–11:55am REVOLVE: efficient exploration of synthesizable chemical space through guided evolution Poster Mon Feb 1 1–2pm qHTS Profiling of the Tox21 10K Compound Library Identifies Antagonists of the β1-Adrenergic Receptor Talk Tue Feb 2 11:30–11:55am AI-Driven Drug Discovery: Accelerating Hit Identification and Optimization Session Tue Feb 2 1–1:45pm 3D Printing and Additive Manufacturing Poster Tue Feb 2 2–3pm From Prediction to Human-Relevant Validation: An Integrated AI, Medicinal Chemistry, and 3D Organoid Workflow for Rabies Antiviral Discovery Talk Wed Feb 3 3–3:25pm High-throughput screening reveals a potent inhibitor of glutathione peroxidase 1 from a decomposed library hit |
Find buyers in assay development and screening
Tell us what you sell and we’ll find the people at organizations working on assay development and screening most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse SLAS2027 by
- Automation and robotics 199
- Assay development and screening 139
- Cell culture and 3D models 115
- Liquid handling and sample prep 109
- Software, data and AI 89
- Detection and imaging 81
- Genomics, synthetic biology and omics 69
- Consumables and labware 67
- Microfluidics and nanotechnology 63
- Sample management and tracking 55
- Clinical and diagnostics automation 25
- New modalities 18
Not affiliated with the Society for Laboratory Automation and Screening. Organization details are derived from SLAS’s published exhibitor list and event scheduler. Submit a correction